Stephens Thinks Welltower’s Stock is Going to Recover

By Austin Angelo

In a report released today, Dana Hambly from Stephens reiterated a Buy rating on Welltower (NYSE: HCN), with a price target of $70. The company’s shares closed yesterday at $60.17, close to its 52-week low of $60.14.

According to, Hambly is a 2-star analyst with an average return of 2.5% and a 50.0% success rate. Hambly covers the Services sector, focusing on stocks such as Encompass Health Corporation, Capital Senior Living, and Team Health Holdings.

Welltower has an analyst consensus of Hold, with a price target consensus of $68.80.

The company has a one-year high of $78.17 and a one-year low of $60.14. Currently, Welltower has an average volume of 1.85M.

Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HCN in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Welltower, Inc. is a real estate investment trust. The company invests with seniors housing operators, post acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.